Area of research
Oncology · Nutrition and Dietetics
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Vitamin C and Antioxidants Research, Pancreatic and Hepatic Oncology Research, and Cancer Genomics and Diagnostics.
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial
Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity
Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer
A Phase II Study of Allogeneic GM-CSF–Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response
Noninvasive Detection of Microsatellite Instability and High Tumor Mutation Burden in Cancer Patients Treated with PD-1 Blockade
Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) Blockade
Intratumoral Adaptive Immunosuppression and Type 17 Immunity in Mismatch Repair Proficient Colorectal Tumors
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade